Wolfe Research analyst Alexandria Hammond initiated coverage of Biogen (BIIB) with a Peer Perform rating.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIIB:
- Raymond James sees EU Leqembi uptake as more modest for Biogen than in U.S.
- Eisai receives positive CHMP opinion for Lecanemab in early Alzheimer’s disease
- EMA recommends Leqembi for treatment of early Alzheimer’s disease
- Biogen up 5% after EMA recommends Leqembi for early Alzheimer’s disease
- American upgraded, Regeneron initiated: Wall Street’s top analyst calls